# clm_1B4BD9A59709

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: research_and_development  
value: 5,278,100,000 United States dollar  
valid_from: 2012-12-31  
valid_to: 2013-12-31  
published: 2013-02-21  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_ADD13B3620DD  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company research and development: 5,278,100,000 United States dollar", as of 2012-12-31 (until 2013-12-31). Claim clm_1B4BD9A59709, https://asof.is/claim/clm_1B4BD9A59709, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947813000007/0000059478-13-000007-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2012, filed 2013-02-21  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947813000007/0000059478-13-000007-index.htm (primary, SEC EDGAR 10-K FY2012, published 2013-02-21)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | research_and_development | 5,020,800,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_1B4BD9A59709](/claim/clm_1B4BD9A59709.md) | [clm_965E7901CE0F](/claim/clm_965E7901CE0F.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.